Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US prepares for imminent Centers for Medicare & Medicaid Services outpatient, ambulatory reimbursement

This article was originally published in Clinica

Executive Summary

When US Medicare proposed sweeping changes in how it calculates diagnosis-related groups (DRGs) under its inpatient payment system earlier this year, it prompted a policy uproar. Analysts weighed in with estimates of earnings losses, while the device industry formed coalitions, commissioned studies, held high-profile press conferences and advertised in key newspapers. Ultimately, the strategy worked. The health plan's proposed payment strategies for both outpatient and ambulatory surgical centres have been treated with far less fanfare.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT053274

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel